Eosinophilic Ulcerative Colitis - Case Report and Literature Review
Recent Advances in Clinical Trials · 2022
DOI: 10.33425/2771-9057.1007 ↗Kurz gefasst
Fallbericht in der Zeitschrift Recent Advances in Clinical Trials, 2022. Verfasst von Isabela Bercovici Soares Pereira und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Eosinophilic colitis (EC) is a rare inflammatory disease that is part of the group of gastrointestinal eosinophilic diseases. Its etiology seems to involve allergic mechanisms comprising several interleukins and immune system cells (mainly eosinophils). It presents in distinct ways according to age, but at any stage of life it encompasses gastrointestinal symptoms. In addition, it is a condition with a predominance in males, according to some studies.
Zitieren
APA
Pereira, I. B. S., Dantas, D. Q., Angelieri, T. D. Y., Tanaka, D. Y., Achar, E., Neto, F. C., & TCBCD, J. K. D. A. G. (2022). Eosinophilic Ulcerative Colitis - Case Report and Literature Review. Recent Advances in Clinical Trials. https://doi.org/10.33425/2771-9057.1007
Vancouver
Pereira IBS, Dantas DQ, Angelieri TDY, Tanaka DY, Achar E, Neto FC, et al. Eosinophilic Ulcerative Colitis - Case Report and Literature Review. Recent Advances in Clinical Trials. 2022. doi:10.33425/2771-9057.1007
BibTeX
@article{Pereira2022,
author = {Pereira, Isabela Bercovici Soares and Dantas, Danilo Queiroz and Angelieri, Taís Donha Yarid and Tanaka, Daniel Yuji and Achar, Eduardo and Neto, Francisco Carillo and TCBCD, João Kleber de Almeida Gentile},
title = {Eosinophilic Ulcerative Colitis - Case Report and Literature Review},
journal = {Recent Advances in Clinical Trials},
year = {2022},
doi = {10.33425/2771-9057.1007}
}
EUVIMED